New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation

scientific article

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(05)64307-3
P698PubMed publication ID9400534

P2093author name stringC A Ludlam
P2860cites workHormone replacement therapy and tumour grade in breast cancer: prospective study in screening unitQ36599062
HRT and breast cancerQ70874274
Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United StatesQ71546196
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast CancerQ28142158
Postmenopausal hormone therapy and mortality.Q34429144
P433issue9092
P407language of work or nameEnglishQ1860
P921main subjectUnited KingdomQ145
hemophiliaQ134003
Creutzfeldt-Jakob diseaseQ49989
P304page(s)1704
P577publication date1997-12-01
P1433published inThe LancetQ939416
P1476titleNew-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation
P478volume350